Evaluation of coronary remodeling after Sirolimus-Eluting stent implantation by serial Three-Dimensional intravascular ultrasound


      This study evaluates the response of the coronary vessel wall to implantation of the sirolimus-eluting stent (SES), Bx-VELOCITY, by using serial intravascular ultrasound. SESs have a major impact on the inhibition of in-stent neointimal hyperplasia. However, changes in the vessel wall and behind stent struts in animal models and humans have not been evaluated after SES implantation. Thirty-four patients who received a SES (n = 24) or a Bx-VELOCITY bare stent (BS) (n = 10) for single de novo coronary lesions and had serial motorized pullback 3-dimensional intravascular ultrasound were included. Stent, lumen, and vessel volumes were similar in the 2 groups at baseline. At follow-up, significantly larger lumen and lower neointimal hyperplasia volumes (0.7 vs 33 mm3, p = 0.001) were seen in the SES group compared with the BS group. There was no significant difference between SES and BS in either the vessel volume (+2.4% vs +0.7%, p = NS) or the plaque behind stent volume change (+3.4% vs +2.5%, p = NS) from after the procedure to late follow-up. The stent edges also showed no significant difference between postprocedural and follow-up measurements, either in patients receiving SESs or BSs. No stented or edge segment required redilatation in the SES group, whereas 2 patients underwent repeat percutaneous coronary angioplasty in the BS group. In the SES group, 1 patient (4%) showed late acquired incomplete stent apposition. Thus, the SES is effective in inhibiting neointimal hyperplasia without affecting vessel volume and plaque behind the stent.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Serruys P.W.
        • Degertekin M.
        • Tanabe K.
        • Abizaid A.
        • Sousa J.E.
        • Colombo A.
        • Guagliumi G.
        • Wijns W.
        • Lindeboom W.K.
        • Ligthart J.
        • de Feyter P.J.
        • Morice M.C.
        Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
        Circulation. 2002; 106: 798-803
        • Hamers R.B.N.
        • Bruining N.
        • Knook M.
        • Roelandt J.R.T.C.
        A novel approach to quantitative analysis of intravascular ultrasound images.
        Comput Cardiol. 2001; 28: 589-592
        • Honda Y.
        • Grube E.
        • de la Fuente L.M.
        • Yock P.G.
        • Stertzer S.H.
        • Fitzgerald P.J.
        Novel drug-delivery stent. Intravascular ultrasound observations from the first human experience with the QP2-Eluting Polymer Stent System.
        Circulation. 2001; 104: 380-383
        • Suzuki T.
        • Kopia G.
        • Hayashi S.-i
        • Bailey L.R.
        • Llanos G.
        • Wilensky R.
        • Klugherz B.D.
        • Papandreou G.
        • Narayan P.
        • Leon M.B.
        • et al.
        Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.
        Circulation. 2001; 104: 1188-1193
        • Gregory C.R.
        • Huie P.
        • Billingham M.E.
        • Morris R.E.
        Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels.
        Transplantation. 1993; 55: 1409-1418
        • Costa M.A.
        • Sabate M.
        • van der Giessen W.J.
        • Kay I.P.
        • Cervinka P.
        • Ligthart J.M.
        • Serrano P.
        • Coen V.L.
        • Levendag P.C.
        • Serruys P.W.
        Late coronary occlusion after intracoronary brachytherapy.
        Circulation. 1999; 100: 789-792
        • Kay I.P.
        • Sabate M.
        • Costa M.A.
        • Kozuma K.
        • Albertal M.
        • van Der Giessen W.J.
        • Wardeh A.J.
        • Ligthart J.M.
        • Coen V.M.
        • Levendag P.C.
        • Serruys P.W.
        Positive geometric vascular remodeling is seen after catheter-based radiation followed by conventional stent implantation but not after radioactive stent implantation.
        Circulation. 2000; 102: 1434-1439
        • Teirstein P.S.
        Living the dream of no restenosis.
        Circulation. 2001; 104: 1996-1998
        • Mudra H.
        • Regar E.
        • Klauss V.
        • Werner F.
        • Henneke K.H.
        • Sbarouni E.
        • Theisen K.
        Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response.
        Circulation. 1997; 95: 363-370
        • Albiero R.
        • Nishida T.
        • Adamian M.
        • Amato A.
        • Vaghetti M.
        • Corvaja N.
        • Di Mario C.
        • Colombo A.
        Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents.
        Circulation. 2000; 101: 2454-2457
        • Kozuma K.
        • Costa M.A.
        • Sabate M.
        • Kay I.P.
        • Marijnissen J.P.
        • Coen V.L.
        • Serrano P.
        • Ligthart J.M.
        • Levendag P.C.
        • Serruys P.W.
        Three-dimensional intravascular ultrasound assessment of noninjured edges of beta-irradiated coronary segments.
        Circulation. 2000; 102: 1484-1489
        • Morino Y.
        • Bonneau H.N.
        • Fitzgerald P.J.
        Vascular brachytherapy.
        J Invasive Cardiol. 2001; 13: 409-416
        • Morice M.C.
        • Serruys P.W.
        • Sousa J.E.
        • Fajadet J.
        • Ban Hayashi E.
        • Perin M.
        • Colombo A.
        • Schuler G.
        • Barragan P.
        • Guagliumi G.
        • Molnar F.
        • Falotico R.
        A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.
        N Engl J Med. 2002; 346: 1773-1780